Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
NCT ID:
NCT01138566
Eligibility Criteria:
Inclusion Criteria:
* Adult patients who admitted to the Taipei Veterans General Hospital with the diagnosis of community-onset UTI caused by Enterobacteriaceae will be eligible for inclusion in this study if hospitalization for parental antimicrobial therapy is required
Exclusion Criteria:
* pregnancy or lactation in women,
* history of serious allergy or intolerance to study drug therapy (patients with a history of mild rash to β-lactams could be enrolled),
* complete obstruction of the urinary tract,
* peri-nephritic or intrarenal abscess, prostatitis, any rapidly progressive disease or terminal illness,
* immuno-compromising illness or immuno suppression therapy, the need for concomitant antimicrobials in addition to study therapy,
* a baseline pathogen resistant to study drug,
* treatment with a systemic antimicrobial agent for \>24 h within 72 h prior to enrolment, or absolute neutrophil count \<1000/mm3.
* Men with a history or physical findings suggestive of acute or chronic prostatitis will also excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01138566
Study Brief:
Protocol Section:
NCT01138566